INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $55,000 | -50.5% | 31,685 | +2.8% | 0.00% | -50.0% |
| Q1 2022 | $111,000 | -43.4% | 30,815 | -21.4% | 0.00% | -33.3% |
| Q4 2021 | $196,000 | -33.8% | 39,207 | -4.9% | 0.01% | -33.3% |
| Q3 2021 | $296,000 | -31.5% | 41,220 | -11.5% | 0.01% | -35.7% |
| Q2 2021 | $432,000 | -38.0% | 46,570 | -37.9% | 0.01% | -44.0% |
| Q1 2021 | $697,000 | +79.6% | 75,011 | +71.3% | 0.02% | +19.0% |
| Q4 2020 | $388,000 | +70.9% | 43,780 | +148.0% | 0.02% | +75.0% |
| Q3 2020 | $227,000 | -37.1% | 17,653 | +32.0% | 0.01% | -50.0% |
| Q2 2020 | $361,000 | -86.6% | 13,376 | +5250.4% | 0.02% | +2300.0% |
| Q2 2014 | $2,703,000 | – | 250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |